Treatment of visceral leishmaniasis in children with liposomal amphotericin B

Journal of Pediatrics

Volumn 131, Issue 2, 1997, Pages 271-277

  Di Martino, L ^a   Davidson, R N ^a   Giacchino, R ^a   Scotti, S ^a   Raimondi, F ^a   Castagnola, E ^a   Tasso, L ^a   Cascio, A ^a   Gradoni, L ^a   Gramiccia, M ^a   Pettoello Mantovani, M ^a   Bryceson, A D M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; INFANT; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARASITOLOGY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY DISTRESS; VISCERAL LEISHMANIASIS;

EID: 0030706193     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)70165-3     Document Type: Article

References (41)

1. TG Evans Leishmaniasis Infect Dis Clin North Am 7 1993 527 546
2. AJ Magill M Grogl RA Gasser W Sun CN Oster Visceral infection caused by Leishmania tropica in veterans of operation Desert Storm N Engl J Med 328 1993 1383 1387
3. PD Mardsen Selective primary health care: strategies for control of disease in the developing world Rev Infect Dis 6 1984 736 744
4. C Dye BG Williams Malnutrition, age and the risk of parasitic disease: visceral leishmaniasis revisited Proc R Soc Lond 254 1993 33 39
5. D Jeannel P Tuppin G Brucker M Danis M Gentilini Imported and autochthonous Kala-azar in France Br Med J 303 1991 336 338
6. JT Moss JP Wilson Current treatment recommendations for leishmaniasis Ann Pharmacother 26 1992 1452 1455
7. D Jeannel P Tuppin G Brucker M Danis M Gentilini Leishmaniasis in France Lancet 2 1989 804
8. P Marty Y Le Fichoux F Pratlong M Gari-Toussaint Human visceral leishmaniasis in Alpes-Maritimes, France: epidemiological characteristics for the period 1985-1992 Trans R Soc Trop Med Hyg 88 1994 33 34
9. M Gramiccia L Gradoni M Troiani HIV- Leishmania co-infections in Italy: isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients Trans R Soc Trop Med Hyg 86 1992 161 169
10. L Gradoni A Bryceson P Desjeux Treatment of Mediterranean visceral leishmaniasis Bull World Health Organ 73 1995 191 197
11. AJ Magill Epidemiology of the leishmaniases Dermatol Clin 13 1995 505 523
12. RK Sellon MM Menard DJ Meuten EJ Lengerich FJ Steurer EB Breitschwerdt Endemic visceral leishmaniasis in dogs from Texas J Vet Intern Med 7 1993 16 19
13. OP Smith IM Hann H Cox V Novelli Visceral leishmaniasis: rapid response to AmBisome treatment Arch Dis Child 73 1995 157 159
14. J Seaman C Boer R Wilkinson J de Jong E de Wielde R Davidson Liposomal amphotericin B (AmBisome) in the treatment of complicated Kala-azar under field conditions Clin Infect Dis 21 1995 188 193
15. R Davidson SL Croft A Scott M Maini AH Moody A Bryceson Liposomal amphotericin B in drug-resistant visceral leishmaniasis Lancet 337 1991 1061 1062
16. RA Gasser AJ Magill CN Oster ED Franke M Grogl JD Berman Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis Clin Infect Dis 18 1994 83 90
17. A Bryceson J Chulay N Mugambi Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine Trans R Soc Trop Med Hyg 79 1985 705 714
18. M Mishra UK Biswas DN Jha AB Kahan Amphotericin versus pentamidine in antimony-unresponsive Kala-azar Lancet 340 1992 1256 1257
19. R Davidson R Russo Relapse of visceral leishmaniasis in patients who were co-infected with human immunodeficiency virus and who received treatment with liposomal amphotericin B Clin Infect Dis 9 1994 560
20. TK Jha YN Giri TK Singh S Jha Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India Am J Trop Med Hyg 52 1995 536 538
21. PC Gokale NA Kshirgasar MU Khan Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B Trans R Soc Trop Med Hyg 88 1994 228
22. R Dietze EP Milan JD Berman Treatment of Brazilian Kala-azar with a short course of Amphocil (amphotericin B cholesterol dispersion) Clin Infect Dis 17 1993 981 986
23. RN Davidson L di Martino L Gradoni Short- course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome) Clin Infect Dis 22 1996 938 943
24. R Davidson L di Martino L Gradoni Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multicentre trial Q J Med 87 1994 75 81
25. CP Takur GP Sinha AK Pandey D Barat RH Singh Daily versus alternate-day regimen of amphotericin B in the treatment of Kala-azar: a randomized comparison Bull World Health Organ 72 1994 931 936
26. L Gradoni R Davidson S Orsini P Betto M Gianbenedetti Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice J Drug Target 1 1993 311 316
27. JD Chulay A Bryceson Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis Am J Trop Med Hyg 32 1983 475 479
28. DA Evans Leishmania AER Taylor JR Baker In vitro methods for parasite cultivation 1987 Academic Press London 52 75
29. M Gramiccia L Gradoni MC Angelici Epidemiology of Mediterranean leishmaniasis caused by Leishmania infantum: isoenzyme and kDNA analysis for the identification of parasites from man, vectors, and reservoirs DT Hart Leishmaniasis: the current status and new strategies for control 1989 Plenum Press New York 21 37
30. L Gradoni A Scalone M Gramiccia HIV- Leishmania coinfections in Italy: serological data as an indication of the sequence of acquisition of the two infections Trans R Soc Trop Med Hyg 87 1993 94 96
31. M Gramiccia L Gradoni L di Martino R Romano D Ercolini Two syntopic zymodemes of Leishmania infantum cause human and canine visceral leishmaniasis in the Naples area, Italy Acta Tropica 50 1992 357 359
32. L Gradoni R Pizzuti A Scalone Recrudescence of visceral leishmaniasis unrelated to HIV infection in the Campania region of Italy Trans R Soc Trop Med Hyg 90 1996 234 235
33. P Bouree L Belec Leishmaniasis: report of 33 cases and a review of the literature Comp Immunol Microbiol Infect Dis 16 1993 251 265
34. L Gradoni M Gramiccia M Pettoello-Mantovani L di Martino A Nocerino A new Leishmania infantum enzymatic variant, agent of an urban visceral case unresponsive to drugs Trans R Soc Trop Med Hyg 81 1987 927
35. PC Melby RD Kreutzer D McMahon-Pratt AA Gam FA Neva Cutaneous leishmaniasis: review of 59 cases seen at the National Institute of Health Clin Infect Dis 15 1992 924 937
36. PF Pimenta SJ Turco MJ McConville PG Lawyer PV Perkins DL Sacks Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut Science 256 1992 1812 1815
37. A Coune Liposomes as drug delivery system in the treatment of infectious diseases: potential applications and clinical experience Infection 16 1988 141 147
38. R Dietze SM Fagundes EF Brito Treatment of kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days Trans R Soc Trop Med Hyg 89 1995 309 311
39. A Llanos-Cuentas J Echevarria J Chang Randomized trial of amphotericin B complex (ABLC) versus Fungizone (F) in patients with mucocutaneous leishmaniasis [abstracts no. We01-7] Proceedings and abstracts of the 13th International Congress for Tropical Medicine and Malaria (Jomtien, Pattaya, Thailand) 1992 Faculty of Tropical Medicine, Mahidol University Bangkok
40. S Sundar HW Murray Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex J Infect Dis 173 1996 762 765
41. R Janknegt S de Marie IAJM Bakker-Woundenberg DJA Crommelin Liposomal and lipid formulations of amphotericin B: clinical pharmacokinetics Clin Pharmacokinet 23 1992 279 291